VentriPoint Diagnostics (CVE:VPT) Stock Price Up 2.4%

VentriPoint Diagnostics Ltd. (CVE:VPT)’s share price rose 2.4% during trading on Thursday . The stock traded as high as C$0.21 and last traded at C$0.21. Approximately 8,070 shares changed hands during mid-day trading, a decline of 92% from the average daily volume of 105,616 shares. The stock had previously closed at C$0.21.

VentriPoint Diagnostics Stock Up 2.4 %

The stock has a market capitalization of C$32.93 million, a PE ratio of -7.00 and a beta of 0.43. The company has a current ratio of 1.17, a quick ratio of 6.67 and a debt-to-equity ratio of 217.41. The company’s 50-day moving average is C$0.22 and its 200 day moving average is C$0.25.

VentriPoint Diagnostics Company Profile

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements.